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CHAPTER 5       DISCUSSION 
 
The problem that initiated the study was the fact that most infants who were 
undergoing hypothermic CPB encountered difficulties elevating PaCO2 and pH using 
pH-stat management. There were several articles in various journals (Peter, 2002) that 
noted that CO2 needed to be added to gas sweep of the bypass circuit to regulate pH-
stat. We never had the same problem with adult cases that was undergoing hypothermic 
CPB. For this reason two hypothermic stage namely moderate and deep hypothermic 
bypass were investigated. Patients were not equally distributed according to 
hypothermic stages. Three different stages of analyses have been done to investigate the 
effect of carbogen intervention. Even though carbogen intervention was carried out only 
during cooling and the stable stage during cardiopulmonary bypass, analyses of data 
were  performed  for  all  stages  as  shown  in  Figure  3.4.  Three  separate  graphs  were  
plotted investigating whole CPB variable analysis (Table 4.3 a & b); PaCO2 analysis 
during CPB (Fig. 4.3 a & b); PaCO2 and pH analysis during cooling and stable stage 
(Fig 4.4 a & b). This is to quantify carbogen intervention at different stages and 
conditions in cardiac surgery. 
Two distinct protocols for acid-base management are used in hypothermic 
cardiopulmonary bypass in clinical practice. Alpha-stat, arterial blood is measured at 
37ÛC, pH 7.40 and PCO2 of 40 mm/Hg, whereas in vivo hypothermic blood is 
hypocapnic and alkalotic. In pH-stat, arterial pH and PCO2 are maintained at constant 
values during cooling, such that pH-stat in vivo hypothermic blood revealed as of and 
pH 7.40, and the PCO2 of 40 mm/Hg, and the arterial blood measured at 37ÛC is 
hypercapnic and acidotic. Hypothermia, which is commonly used during CPB, can lead 
to decreased organ perfusion from vasoconstriction resulting, at least in part, from the 
reduction of the partial pressure of CO2. 
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Baseline arterial blood gases in this study are not appropriate for use as a 
reference range because all infants are induced and intubated and ventilated before an 
arterial line is obtained. This may directly influence the baseline which could be 
considered as reference range in this study. Thorough studies have to be done to observe 
reference range of arterial blood gases in infant before any intervention is carried out. 
The reference range is universally accepted as a guideline for hemodynamically stable 
blood gases. When an intervention on PaCO2 is carried out, it should be remembered 
that a PaCO2 range that high is more difficult to correct with hyperventilation than low 
PaCO2 which is easier to be corrected with ventilation or bicarbonate.  
Clinically, if the starting point is a pCO2 of 40 mm/Hg, a mathematical 
relationship can be shown. If the arterial pCO2 increases by 20 mm/Hg, arterial pH will 
decreases by 0.20. If arterial pCO2 decrease by 10 mm/Hg, pH will increase by 0.10. 
Alkalosis is present when the body has an increased pH: it is caused by either a 
respiratory or a metabolic factor. Respiratory alkalosis is caused by too much carbon 
dioxide being removed by the oxygenator on CPB and this is caused by excessive 
sweep gas to remove CO2. 
For this study, pCO2 regulation was adjusted accordingly to gas sweep for 
control  groups  and  gas  sweep  was  kept  at  a  minimum  with  additional  intervention  of  
carbogen for treatment groups. For each oxygenator (Capiox RX05 and Minimax Plus) 
the control and treatment groups to determine if carbogen intervention was necessary 
for an infant undergoing hypothermic bypass. Specifications of both oxygenators are 
shown in Table 5.1. Blood gas was corrected according to actual temperature of the 
patients, utilizing pH-stat management for both control (without carbogen) and 
treatment (with carbogen). The carbogen treatment was introduced to determine if we 
can overcome the problem of maintaining pH and PCO2 for any infant undergoing 
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hypothermic bypass. Since the gas solubility increased with decreasing temperature, the 
partial pressure of CO2 decreased, although the total content does not change. 
Table 5.1: Specifications for Capiox RX 05 and Medtronic® Minimax Plus® hollow-
fiber membrane oxygenators 
 
 
 
Variables 
 
Terumo Capiox RX 05 
(Baby RX) 
 
Medtronic® Minimax 
Plus® Hollow Fiber 
Oxygenator 
 
 
Blood flow rate (L/min) 
 
0.1 to 1.5 0.5 to 2.3 
 
Reservoir 
 
Hardshell narrow bottom Hardshell broad bottom 
 
Static priming volume 
(mL) 
 
43 149 
 
Reservoir capacity (mL) 
 
1000 2000 
 
Surface treatment/ coating 
 
‘X coating®’ (PMEA-based 
polymer) 
Minimax plus 3381 – 
without Carmeda Bioactive 
 
Minimum reservoir 
operating level (mL) 
 
15 150 
 
Vacuum Assisted Venous 
Drainage (VAVD) 
 
Applicable Not applicable 
 
Hollow-fiber material 
 
Polypropylene Polypropylene 
 
Bundle Surface area 
 
0.5 m2 0.9 m2 
 
Oxygenator orientation 
 
Horizontal Vertical 
 
Oxygenator & Reservoir 
 
Integrated Non-integrated 
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Hypocapnia, which results in alkalosis, has hazardous effects (Figure 5.1) on 
lung mechanics, cerebral blood flow, and the cardiovascular system. Both alkalosis and 
hypocapnia have been shown to increase pulmonary resistance and decrease lung 
compliance, which may lead to severe problems, especially in the weaning phase of 
CPB (Bayindir et al., 2000; Coon et al., 1975). In an isolated buffer-perfused lung 
model, Laffey et al. (2000) demonstrated that hypocapnic alkalosis is directly injurious 
to the lung and potentiates ischaemia/reperfusion induced acute lung injury. 
Although cerebral oxygenation is autoregulated during cardiac surgery before 
and after CPB, it has been demonstrated that, during CPB, haemoglobin, temperature, 
pH, and pCO2 determine at least 85% of all changes in cerebral oxygenation and the 
main causes of impaired cerebral oxygenation are a decrease in Hb with haemodilution, 
vasoconstriction due to hypocapnia, and leftward shift of haemoglobin binding curve in 
alkalosis and hypothermia (Nollert et al., 1995). 
Variations of PaCO2 also affect systemic haemodynamics. It has been shown 
that hypocapnia (PaCO2 = 30 mmHg) significantly decreases cardiac index by 9%, 
which has been associated with an inverse change in systemic vascular resistance index 
(Kazmaier et al., 1998). Recently, Mas et al. (2000) demonstrated that acute hypocapnia 
(PaCO2 from 41 to 34 mmHg) resulted in a significant increase in systemic vascular 
resistance  and  oxygen extraction  ratio.  In  our  study,  PaCO2 decreased significantly in 
both oxygenators (Capiox RX05 and Minimax Plus) control groups compared to 
treatment  groups  after  initiation  of  CPB  (cooling  phase).  Hypothermia  and  prolonged  
CPB time further aggravated these changes, and at stable phase, may produce 
nonphysiologic values in pCO2 and pH. At the end of the rewarming period, with 
increased carbon dioxide production, pCO2 values were elevated for both oxygenators 
regardless of either control or treatment groups.  
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                                                            pH:          >7.45                             7.35-7.45                       <7.35 
 
 
                                                       pCO2:         <35mm/Hg                    35-45mm/Hg                 >45mm/Hg 
 
 
 
     ETCO2:      <35mm/Hg                    35-37mm/Hg                 >37mm/Hg 
 
                                                    
 
                                                            
                                                            
  
 
 
 
 
Figure 5.1: Hypothermia causes respiratory alkalosis.
 
pCO2 
Ca2+ entry 
Kinetic energy 
H+ Ion 
H2O Ionization 
Bld Flow to Organs 
Alkalosis Normal Range Acidosis 
Hypothermia Problems 
Natural Alkaline Shift 
Blood vessel vasoconstric 
 
Restrict membrane permeability 
55 
 
The major limitation of this study is the use of a nonrandomized study design 
that could lead to bias in the patient’s selection for to control and treatment groups. 
Although patients undergoing congenital heart disease correction (Figure 5.2) had 
similar baseline demographic characteristics within oxygenator group there was a 
difference in baseline between oxygenators. Federspiel and Hattler (1996) presented a 
simple analysis and graphic result for characterizing the effect of sweep gas flow rate on 
CO2 exchange in artificial lungs. The analysis and its application require no detailed 
knowledge of the blood-side or membrane mass transfer characteristics; neither of the 
artificial lung device, nor of gas flow or blood flow pathways through the device. 
Neither does it require detailed mathematical or computer modelling of transport 
processes ongoing within the device. Rather, the analysis exploits a useful 
normalization  to  simply  relate  CO2 exchange  rate  within  artificial  lungs  to  sweep  gas  
flow rate, independent of device specific flow and mass transfer complexities. Thus, 
although a specific model oxygenator was used, recommendations for sweep rates 
obtained from this study may be universally applied to all membrane oxygenators. 
Indeed, haemoglobin buffers the hydrogen ions produced by CO2 hydration to 
bicarbonate and directly combines with some CO2 to form compounds of a carbamino 
type (Roughton, 1964). Haemodilution also decreases blood capacity for transporting 
both O2 and CO2 (Cavaliere, 2000). 
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 Figure 5.2: Operation theatre arrangement for open heart surgery with carbogen treatment.
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5.2 Paediatric cardiac surgeries 
 
Paediatric cardiac surgery involves several stages from preparing the patient to 
the intensive care after the surgery. Firstly the, patient is given a premedication and an 
intravenous anaesthetic just before the operation. When patient is unconscious, 
intubation and ventilation is performed. Secondly, the transoesophageal 
echocardiographic (TOE) probe insertion into patients on surgical table is performed. 
TOE is a flexible tube, about the width of a finger, with a small ultrasound probe on the 
end. With correct placement, it allows visualization of the structure of the heart. Third 
stage involves the surgeon, as he cuts through the patient’s breastbone to gain entry to 
the thorax. This enables direct access to the heart after exposing the pericardium. By the 
fourth stage the patients heart is cannulation. Once the pericardium has been opened the 
surgical team cannulates the aorta and right atrium for many of the cases and connects 
patients’ heart to the heart-lung bypass machine. Different surgical team performed a 
variety of surgeries for individual cardiac diagnoses. The fifth stage involves 
cardiopulmonary bypass monitoring to ensure properly maintained circulation and 
oxygenation of patients’ blood. During this period the surgical team will perform the 
surgical correction to the heart. Sixth stage is final phase whereby ventilation, intensive 
care  and  recovery  take  place  (Figure  5.3).  Postoperative  care  was  provided  in  the  
paediatric intensive care unit (PICU), with management provided by members of 
paediatric cardiology, paediatric critical care nurses, and cardiothoracic surgery staff. 
Currently patients were monitored continuously with Philips software called Intellivue 
Clinical Information Portfolio (ICIP) System. This is a computer-based system linked to 
a central monitoring station but for this study manual data collection has been utilized.  
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Figure 5.3: Paediatric cardiac surgery. A: Premedication and anaesthesia; B: Passing the transoesophageal echocardiographic (TOE) probe; C: Opening 
the chest and preparing the heart; D: Cannulations; E: Performing CPB; F: Post-operative care
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5.3 Limitations and comments 
 
Oxygenators’ evolution began with using lung as natural gas exchange through 
ventilation support to the lung. Evolution of oxygenator began with the invention of 
bubble oxygenator and led to the modern membrane oxygenator. A membrane 
oxygenator can be divided into microporous polypropylene (0.3 to 0.8 µm pores) or 
silicone rubber oxygenator at current generation. Although this study was randomized 
controlled trial, there are some limitations. Firstly, ventilation through a GA machine is 
vital for the patients in the operation theatre. Typically, arterial blood gas (baseline 
reading) will be performed after ventilation is secured in infant. An ABG performed 
after ventilation is to evaluate oxygenation adequacy. There are differences between 
ventilated patients and natural atmospheric breathing patient which could lead influence 
the pCO2 reading during baseline ABG. It is therefore important to obtain ABGs from 
ventilated infant patient before, during and after bypass. Meanwhile during bypass, 
minimal ventilation is performed by the anaesthetist to prevent atelectasis or “collapse 
of  the  patients’  lung”  after  the  bypass  is  terminated.  Air  and  O2 are insufflated in 
different ratios depending on anaesthetic decision. This minimum ventilation to infant’s 
lung might influence pCO2 content in patient’s blood but the influences of it are not 
significant for this study. Sometime, a hyperventilation intervention is applied to 
decrease entidal CO2 before or after cardiopulmonary bypass. A few post-CPB cases 
that received hyperventilation might or might not be related to carbogen treatment. 
Further study in this matter should be continued to answer the questions raised. 
Length of the surgery may vary according to cases. In some cases, surgeons are 
required  to  go  back  on  CPB  several  times  depending  on  the  diagnosis  of  TEE  or  
readings on blood pressure of particular blood vessels. This might in turn affect ABG 
results, create electrolyte imbalance, reperfusion injury, lung injury, etc. Furthermore, 
surgeons who perform different methods of surgical correction from the case may cause 
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the length of the particular surgery to be prolonged and in turn influences CO2 build-up 
in body of the patient. Cases with bypass time less than 60 min do not affect ABG result 
especially during cooling or stable period. This situation is almost frequently seen in 
mild hypothermia patient when the surgery is short. 
Patients’ body temperature can be distorted by a few factors in the operation theatre. 
This includes operation theatre temperature, absence of humidifier with heating 
element, body surface area and time duration for chest closure. Additionally, 
nasopharyngeal temperature with temperature probe inserted in nasal cavity of an infant, 
may be affected by ventilation via GA machine without a heated humidifier. This 
situation causes both pre and post bypass temperature to drop by 2 to 5ÛC despite the 
use  of  bed  warmer  or  blower  for  some  cases.  Pre-operative  or  baseline  nasal  
temperature may vary from one infant to another. Pre-operative ABG were performed 
with the normal body temperature of an infant assumed as 37ÛC. This is because nasal 
temperature probe is inserted later than arterial line insertion. ABG results during 
surgery should be based on arterial line temperature (on heart-lung machine) rather than 
patients’ nasal temperature for accurate ABG reading. Duration of CPB cooling varies 
between cases, contributing to pCO2 regulation in patients and carbogen usage. 
Hypothermia increases the solubility and affinity of oxygen and carbon dioxide. During 
rewarming on bypass there was an increase in cerebral fraction oxygen extraction (FOE) 
only in patients who had a continuous flow bypass (SP Wardle et al., 1998). In this 
study carbogen treatments are stopped during rewarming. Moreover, CO2 production is 
higher during rewarming and therefore caution must be used not to hyperventilate the 
patient which may lead the patient to hypocapnia. 
Carbogen treatment causes a few problems, interms of setting-up and delivery. 
Setting-up the carbogen requires extra time beside the normal check-up and priming of 
CPB machine. Moreover, pO2 level during CPB easily reaches more than 600mm/Hg 
61 
 
even  if  FiO2 adjusted at 21% because carbogen has been delivered at 1L/min (Table 
5.2).  
 
Table 5.2: Advantage and disadvantage using carbogen to treatment of pH-stat 
management during hypothermia. 
 
Carbogen Usage During CPB 
Advantage Disadvantage 
pCO2 level elevated at any gradient 
temperature 
High pO2 level 
Dilates vessel during hypothermia 
(cerebral oxygenation increase) 
Expensive 
Increased pH level caused by respiratory 
alkalosis are treatable 
Consumes time for set-up 
 Occupies extra space 
 Need titration 
 
Extra monitoring devises have to be 
applied to monitor carbogen intervention 
 
This phenomenon might influence hyperoxemia or oxygen toxicity. PCO2 level  is  
elevated together with the elevation of PO2. Hyperoxemia has adverse effects such as 
the presence of reactive oxygen species. These endogenous antioxidants cause cellular 
damage. At the same time it has also been used to reduce nitrogen bubbles (Justin, 
2006). Air blenders are kept at a minimum FiO2 of 0.2 and gas sweep at 0.1L/min in 
order to flush in sevoflurane from circuit to the oxygenator. Generally, the higher the 
pump flow the greater the oxygenator’s capillary area, the more carbogen is used. 
Excessive gas flow may cause low pCO2, alkalosis, or blood damage (Terumo 
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Cardiovascular Systems; 2003). Carbogen is an expensive gas. It has to be prepared 
with oxygen (95%) and carbon dioxide (5%), and stored in cylinders of capacity 
1.4m3/10L. The usage depends on flow, bypass time (cooling to rewarming period) and 
surface area of the oxygenator’s fiber. Carbogen usage may also vary depending on the 
length of surgery or the temperature that patients have to be cooled to: mild, moderate 
or deep hypothermia. In addition, we personally had difficulty with carbogen supply as 
the factory which produced them had a technical problem causing a delay. There were a 
few cases which were in the treatment group but the pCO2 readings were constantly in 
normal range during CPB and needed no carbogen usage.  
The infant’s small body size and immature thermoregulation sensory receptors 
development challenge CPB being performed on them. There are also anatomical 
problems of the congenital heart. Furthermore, the heat loss from an infant is faster than 
in adult. BSA of an infant is small and this causes a lesser CO2 production, in 
comparison  with  an  adult  who  can  produce  reasonable  CO2 for compensation. Gas 
sweep that is integrated with heart-lung machine is not sufficient to increase the CO2 
level even if gas sweep are decreased to a minimum level (0.1 l/min). 
Perfusion techniques may vary from one to another perfusionist. Priming solution 
usually contain Plasmalyte, Albumine 20%, Mannitol 10%, Packed cell (1 unit), and 
sodium bicarbonate and other drugs. Perfusionist should balance this priming solution 
in the circuit at the onset of the surgery by correcting electrolyte and gases according to 
blood’s normal range by performing an ABG investigation before going on bypass. 
CPB influences CO2 production in patients’ body by a few factors; haemodilution, 
hemofiltration, hyperperfusion or overflow into patient circulation. Usage of 
Phenylephrine as a vasoconstrictive agent might restrict CO2 exchange, intra or 
extracellular. CO2 flush is not applied for this study even though it is recommended for 
both oxygenator before priming. The aim of CO2 flush before priming is to make it easy 
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for de-bubbling macro and micro air from the circuit. Nevertheless, we practice 
warming-up the heat exchanger to 36ÛC during priming to de-bubble properly before 
surgery.   
Capnograph is a device used to evaluate mean CPB pump expired carbon dioxide 
(peCPBCO2)  through  oxygenator  gas  outlet.   FiO2 and gas sweep adjustment alter 
capnograph reading [peCPBCO2 (mm/Hg)]. peCPBCO2 decrease when FiO2 increase 
and vice versa. There is an isolated incidents where the capnography reading showed 8 
to  9  mm/Hg  paCO2 but the ABG showed pCO2 = 30mm/Hg during or just into 
rewarming stage indicating a possible ventilation perfusion problem. Scavenging line 
outlets are vulnerable to water condensation,  as the exhaled air are cooled and are 
warmed-up in a heat exchanger before passing through the capnography to 
measurement of peCPBCO2. These water condensation alter the peCPBCO2 reading and 
block the air passing through. Caution is taken to prevent the water blocking the 
capnography reading. Scavenging line is also susceptible to be stepped on or wheeled 
over. This can prevent wall suction and reading from capnography may drop for the 
period the line is kinked or stepped on (Figure 5.4). From the observation, 
haemodilution decreased end-tidal CO2 immediately. Time is required for the machine 
to capture the carbon dioxide from the oxygenator gas outlet. In some case a few minute 
are required for accurate reading of the machine. Thus there is a debate on parameter to 
use: End-tidal CO2 or blood gas measurement. End-tidal CO2 measured through 
capnography is a more economical way to monitor CO2 from exhaled gas from patient 
or oxygenator. It is recommended however to use blood gas monitoring device such as 
inline monitoring CDI 500 or ABG machine (Cobas b 211 system) to confirm blood 
gases. There are few other problems faced by perfusionist during the handling of the 
heart-lung machine with the accessory machinery required during this study. 
Difficulties include the handling of different types of ABG machine. The machines in 
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used  are  Cobas  b  221  system,  Roche  Diagnostics;  ABL  700  series,  Radiometer  
Copenhagen; CDITM 500 Blood Parameter Monitoring Systems, Terumo Cardiovascular 
Systems, USA; and i-STAT® 1 Analyzer, Abbott, East Windsor, NJ, USA: using CG8+ 
cartridge which may alter the ABG result. CDI 500 system is an in-line blood gas 
monitoring device which has been used in this study for monitor and adjustment of 
carbogen delivery and allows a continuous measurement of PaO2, PaCO2,  pH, K+ and 
temperature as well as haematocrit, haemoglobin and the saturation of haemoglobin in 
venous blood (Svo2). But, there are a few problems noted during usage of CDI 500 
system. The most obvious observation is in the actual temperature measurement that 
might be influenced by heat loss from monitoring line connected in and out of arterial 
shunt sensor. Moreover, using CDI 500 system in infant circuit causes extra-shunting in 
ECC circuit but this is balanced by the availability of electrolyte and blood gases 
analyse.    
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Defect’s in ¼ tubing filter at critical gas supply 
line restrict delivery of desired gas to 
oxygenator. 
 
Scavenging line has to be secured 
along the line to prevent accidental 
stepping on the tubing or kinks 
caused by instruments. 
 
 
 
 
 
 
 
Water condensation through-out line 
connecting exhaust gas outlet from oxygenator 
to capnography may alter peCPBCO2 reading 
at GA machine. 
 
Wall suction should always be 
checked when scavenging line is in 
use to prevent false positive result. 
 
Figure 5.4: Common troubleshooting that happens during carbogen treatment. 
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Even though the shunting is small, but in combination with other shunts such as 
hemofiltration,  the  sampling  line  may cause  a  drop  in  ABP of  patient.  To  counter-act  
this situation, perfusionists have to increase the flow of the main pump.  CDI 500 
system does not have Na+, Ca2+ and glucose parameter measurements, which have to be 
confirmed by regular ABG machine, before, during and after cardiopulmonary bypass. 
The length of time to perform ABG analysis and bubble formed in syringes containing 
patients’ samples may influence ABG result. Minimal values of FiO2 and gas sweep 
have to be determined to get adequate sevoflurane delivered to patients’ blood. 
Currently, carbogen is connected after the gas blender and sevoflurane outlet. Full 
utilization of carbogen may be strategically located to maximize sevoflurane usage as 
well. An isolated incident happened when the O2 line tubing which contained filter 
leaked out air, before passing into the oxygenator and preventing accurate gas delivery. 
The oxygen line tubing filter, which filters out any micro-particle from gas line may 
have cracks, or are not well sealed. These human error or manufacturing faults may 
cause air, O2 and anaesthetic gas to leakage before reaching the oxygenator. 
A few questions arose during the period of this research. Firstly, how does the 
metabolism of NaHCO3 influence pCO2 in patient’s blood? Secondly, in this research 
we observed that patient’s blood pressure had a relationship with pCO2 of patient and 
further studies should be done to optimize the correlation. The condition whereby the 
pCO2 reached optimum level the blood pressures increased or optimized for paediatric 
case are noted. Thirdly, all measurements are based on extracellular CO2. What is the 
influence of intracellular CO2 on patient’s metabolism? Fourthly, CO2 production versus 
consumption is patient related. Various factors influence CO2 production and 
consumption in general. Examples of these various factors are temperature, 
oxygenation, full flow and gas blender adjustment. The present study is limited by the 
fact that no measurements were performed in the late phase of CPB to investigate 
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whether these observations are time related and/or whether they persists into intensive 
care period. Finally, oxygenator position or alignment may affect gas exchange 
according to gravitational force which may need further depth study. For example 
between the two groups of oxygenator that were being studied Capiox RX05 had a 
horizontal position while Medtronic Minimax had the vertical oxygenator position. A 
few cases that were noted that did not required carbogen as treatment to elevated the 
pCO2. These cases have pCO2 level normalized through-out the CPB. Careful note on 
circumstances that provided the condition would have been needed.   
Observation showed that ABP of the patient have a relationship with fluctuation of 
pCO2 level during CPB. A more comprehensive study should be performed to evaluate 
the relationship between ABP and pCO2 for patients undergoing open heart surgery. If a 
normal range of pCO2 achieved, in blood ABP desirable ABP can be recorded. There is 
pressure difference between body of a bypass patient and diver’s. There is a possibility 
of using a technique of re-breathing for longer CPB time according to temperature (with 
specific air recycler and utilize air and oxygen sufficiently). Another area of 
advancement that could be considered is a nanobiotechnology breakthrough in 
development of membrane fiber oxygenators to support maximum gas exchange. A 
temperature auto-regulation of blood gases might be achieve by integrating towards 
membrane oxygenator to improve patients outcome in the future. Rather than 
integrations between oxygenator and arterial filter in current generation, option should 
be explored for intelligent fiber material that self-correct blood gases according to 
temperature and overcome clot formation from drug interaction. Given the nature of the 
underlying heart disease, the need for expedience, and the fact that existing heart failure 
may confound the outcome of the study which limits further evaluation of postoperative 
outcomes. 
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CHAPTER 6      CONCLUSIONS 
 
From the present study, we conclude that carbogen usage improves the 
percentage of PaCO2 and  pH  level  falling  within  the  reference  range  as  compared  to  
control group. Sweep-gas flow adjustment alone would not be sufficient to control 
PaCO2 during all phases of CPB for paediatric patient. For this reason carbogen 
intervention is helpful to regulate PaCO2 as treatment group during CPB at moderate 
and deep hypothermia for both types of oxygenators. Results on oxygenators show that 
Capiox RX05 is more carbogen dependent than Minimax Plus. Furthermore, this study 
provides a better understanding of the relationship between temperature gradient and 
carbogen usage to regulate pCO2 and pH during CPB. It is hoped to be present study 
provides an avenue for future investigations into the efficiency of carbogen usage 
during CPB according to age group and temperature gradient can be done in 
randomized control trial manner. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
